Jasper Therapeutics, Inc.
JSPR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $5.05M in total; no superinvestor holds it.
Other share classesJSPRW
13F holders, Q1 2023
Institutional positions in Jasper Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +23 vs. Q4 2022
- Shares held
- 93.6M
- +79.0M (+540.4%) vs. Q4 2022
- Total value
- $168.8M
- +$162.0M (+2,364.7%) vs. Q4 2022
- New holders
- 28
- 14 more added
- Sold out
- 5
- 2 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JSPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $5.05M |
| Q1 2026 | 58 | $13.9M |
| Q4 2025 | 55 | $35.2M |
| Q3 2025 | 60 | $47.8M |
| Q2 2025 | 65 | $69.5M |
| Q1 2025 | 69 | $56.1M |
| Q4 2024 | 88 | $334.5M |
| Q3 2024 | 81 | $274.8M |
| Q2 2024 | 69 | $329.8M |
| Q1 2024 | 61 | $380.2M |
| Q4 2023 | 42 | $61.2M |
| Q3 2023 | 41 | $63.7M |
| Q2 2023 | 46 | $120.0M |
| Q1 2023 | 45 | $168.8M |
| Q4 2022 | 23 | $9.57M |
| Q3 2022 | 23 | $15.7M |
| Q2 2022 | 23 | $37.5M |
| Q1 2022 | 24 | $69.6M |
| Q4 2021 | 25 | $160.7M |
| Q3 2021 | 9 | $101.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Jasper Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Steward Partners Investment Advisory, LLC | 350 | $634 | 0.00% | +350 | New |
| Cutler Group LP | 900 | $1.00K | 0.00% | +900 | New |
| Wells Fargo & Company | 762 | $1.38K | 0.00% | +492+182.2% | Added |
| Susquehanna International Group, LLP | 13,822 | $25.0K | 0.00% | −20,544−59.8% | Reduced |
| One68 Global Capital, LLC | 20,000 | $36.2K | 0.05% | +20,000 | New |
| Forefront Analytics, LLC | 30,290 | $54.8K | 0.03% | −83,710−73.4% | Reduced |
| Goldman Sachs Group Inc | 31,041 | $56.2K | 0.00% | +31,041 | New |
| Jump Financial, LLC | 33,074 | $59.9K | 0.00% | +33,074 | New |
| Charles Schwab Investment Management Inc | 36,899 | $66.8K | 0.00% | +36,899 | New |
| Two Sigma Investments, LP | 42,253 | $76.5K | 0.00% | +42,253 | New |
| Bank of New York Mellon Corp | 43,593 | $78.9K | 0.00% | +43,593 | New |
| Prelude Capital Management, LLC | 54,500 | $98.6K | 0.01% | +54,500 | New |
| Millennium Management LLC | 54,718 | $99.0K | 0.00% | +25,047+84.4% | Added |
| Citigroup Inc | 64,810 | $117.3K | 0.00% | +64,810 | New |
| Man Group plc | – | $135.7K | 0.00% | – | New |
| Renaissance Technologies LLC | 110,200 | $199.0K | 0.00% | +44,800+68.5% | Added |
| Squarepoint Ops LLC | 139,887 | $253.2K | 0.00% | +139,887 | New |
| Northern Trust Corp | 155,286 | $281.1K | 0.00% | +133,826+623.6% | Added |
| State Street Corp | 199,094 | $360.4K | 0.00% | +166,210+505.4% | Added |
| Jane Street Group, LLC | 211,010 | $381.9K | 0.00% | +211,010 | New |
| Boothbay Fund Management, LLC | 233,407 | $422.5K | 0.01% | +233,407 | New |
| Morgan Stanley | 378,072 | $684.3K | 0.00% | +375,022+12,295.8% | Added |
| Fernwood Investment Management, LLC | 454,706 | $823.0K | 0.32% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 476,948 | $863.3K | 0.33% | +476,948 | New |
| Silverarc Capital Management, LLC | 500,000 | $905.0K | 0.41% | +500,000 | New |
| Geode Capital Management, LLC | 1,070,314 | $1.94M | 0.00% | +942,898+740.0% | Added |
| Ikarian Capital, LLC | 1,126,287 | $2.04M | 0.85% | +1,126,287 | New |
| BlackRock Inc. | 1,256,517 | $2.27M | 0.00% | +1,042,394+486.8% | Added |
| Nantahala Capital Management, LLC | 1,688,454 | $3.06M | 0.29% | +1,688,454 | New |
| Bank of America Corp | 1,781,583 | $3.22M | 0.00% | +1,781,547+4,948,741.7% | Added |
| RTW Investments, LP | 2,329,809 | $4.22M | 0.09% | +2,329,809 | New |
| Ally Bridge Group (NY) LLC | 2,517,232 | $4.56M | 5.97% | +2,517,232 | New |
| Woodline Partners LP | 3,000,000 | $5.43M | 0.08% | +3,000,000 | New |
| Kingdon Capital Management, L.L.C. | 3,040,000 | $5.50M | 1.29% | +2,500,000+463.0% | Added |
| Vanguard Group Inc | 3,726,147 | $6.74M | 0.00% | +3,195,709+602.5% | Added |
| Driehaus Capital Management LLC | 4,000,000 | $7.24M | 0.10% | +4,000,000 | New |
| Citadel Advisors LLC | 4,013,038 | $7.26M | 0.01% | +877,998+28.0% | Added |
| Sphera Funds Management Ltd. | 4,044,008 | $7.32M | 1.58% | +4,044,008 | New |
| Franklin Resources Inc | 4,500,217 | $8.15M | 0.00% | +4,500,217 | New |
| Octagon Capital Advisors LP | 6,382,500 | $11.6M | 1.67% | +6,382,500 | New |
| Soleus Capital Management, L.P. | 7,454,980 | $13.5M | 1.67% | +7,454,980 | New |
| Qiming U.S. Ventures Management, LLC | 8,519,648 | $15.4M | 18.66% | +2,666,666+45.6% | Added |
| Carlyle Group Inc. | 8,761,891 | $15.8M | 0.47% | +8,761,891 | New |
| BVF Inc | 9,900,000 | $17.9M | 0.66% | +9,900,000 | New |
| Velan Capital Investment Management LP | 11,219,036 | $19.6M | 17.39% | +8,000,000+248.5% | Added |
| UBS Group AG | 0 | $0 | 0.00% | −215,521−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,494−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −12,839−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Abingworth LLP | – | – | – | – | Not filed |